GVD

Hodgkin disease

salvage regimen in relapsed Hodgkin's lymphoma

Regimen

For transplant-naive patients:

• Gemcitabine (Gemzar) 1000 mg/m2 iv d1, 8
• Vinorelbine (Navelbine) 20 mg/m2 iv d1, 8
• Pegylated liposomal doxorubicin (Doxil) 15 mg/m2 iv d1, 8

Q3w

For post-transplant patients:

• Gemcitabine (Gemzar) 800 mg/m2 iv d1, 8
• Vinorelbine (Navelbine) 15 mg/m2 iv d1, 8
• Pegylated liposomal doxorubicin (Doxil) 10 mg/m2 iv d1, 8

Q3w

References

Bartlett NL et al. Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Ann Oncol 2007; 18:1071